Why is Tatva Chintan falling/rising?

As of 15-Sep, Tatva Chintan Pharma Chem Ltd is experiencing a price increase, currently at Rs 1,062.20, which reflects a rise of Rs 45.15 or 4.44%. The stock has shown strong performance today, outperforming its sector by 3.86% and achieving a consecutive gain over the last three days with a total return of 5.38%. It has also been trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Notably, despite a recent decline in delivery volume by 29.68% against the 5-day average, the company maintains a low debt-to-equity ratio of 0.07, indicating financial stability. Over the past year, while the broader market has faced negative returns, Tatva Chintan has managed to generate a positive return of 9.13%.
In the broader market context, Tatva Chintan's short-term performance has significantly outpaced the benchmark, with a 1-week return of 8.09% compared to the Sensex's 1.24%. This strong performance is particularly noteworthy given that the stock has been able to deliver positive returns even when the BSE500 index has declined by 3.45% over the last year. The company's ability to outperform the market, combined with its solid financial metrics, suggests that investor confidence remains strong, contributing to the upward movement in its stock price.